Stockreport

Supernus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Profit margin: 22% (up from net loss in 3Q 2023). The move to profitability was primarily driven by lower expenses. EPS: US$0.70 (up from US$0.29 loss in 3Q 2023). [Read more]